The impact of childhood RSV infection on children's and parents' quality of life: a prospective multicenter study in Spain

被引:21
|
作者
Diez-Gandia, Eva [1 ]
Gomez-Alvarez, Carla [2 ]
Lopez-Lacort, Monica [2 ]
Munoz-Quiles, Cintia [2 ]
Ubeda-Sansano, Isabel [3 ]
Diez-Domingo, Javier [2 ]
Orrico-Sanchez, Alejandro [2 ,4 ]
机构
[1] Hosp Lluis Alcanys, Valencia, Spain
[2] FISABIO Publ Hlth, Fdn Fomento Invest Sanitaria & Biomed Comunitat, Vaccine Res Dept, Valencia, Spain
[3] Hlth Care Ctr Eliana, Valencia, Spain
[4] Univ Catolica Valencia San Vicente Martir, Valencia, Spain
关键词
Health-related quality of life; Respiratory syncytial virus; Children; Quality-adjusted life years; Respiratory disease; RESPIRATORY SYNCYTIAL VIRUS; COST-EFFECTIVENESS; HEALTH OUTCOMES; VALIDITY; DISEASE; QUESTIONNAIRE; RELIABILITY; POPULATION; BURDEN; INFANT;
D O I
10.1186/s12879-021-06629-z
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Several immunisation candidates against RSV are in late-stage clinical trials. To evaluate the benefits of a potential vaccination programme, both economic and health benefits will be needed. Health benefits are usually measured in Health-related Quality of Life (HRQoL) loss using standardised questionnaires. However, there are no RSV-specific questionnaires validated for children under 2 years, in whom most RSV episodes occur. Therefore, HRQoL estimates are taken from literature or inadequate tools. We determined HRQoL loss and direct costs due to an RSV episode in children younger than 2 years and their caregivers during a month of follow up, using a new questionnaire administered online. Methods An observational prospective multicentre surveillance study was conducted in children aged younger than two years. Children were recruited from 8 primary care centres and 1 hospital in the Valencia region and Catalonia (Spain). RSV-positive cases were obtained by immunochromatographic test. HRQoL was assessed using a new ad-hoc 38 item-questionnaire developed. Parents of infected children completed 4 questionnaires at four timepoints (day 0, 7, 14 and 30) after diagnosis. Results 117 children were enrolled in the study and 86 (73.5%) were RSV + . Median (interquartile range; IQR) scores were 0.52 (0.42-0.68), 0.65 (0.49-0.79), 0.82 (0.68-0.97) and 0.94 (0.81-1), for days 0, 7, 14 and 30, respectively. Compared to total recovery (Q30), HRQoL loss was 37.5%, 31.5% and 8.9% on days 0, 7 and 14 since diagnosis of the disease. The total median cost per patient (including treatments) was euro598.8 (IQR: 359.63-2425.85). Conclusions RSV had almost 40% impact on HRQoL during the first week since onset of symptoms and the median cost per episode and patient was about euro600. These results represent a substantial input for health-economic evaluations of future RSV-related interventions such as vaccination.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Quality of life of transplanted children and their parents: a cross-sectional study
    Duvant, Pauline
    Fillat, Magali
    Garaix, Florentine
    Roquelaure, Bertrand
    Ovaert, Caroline
    Fouilloux, Virginie
    Tsimaratos, Michel
    Auquier, Pascal
    Fabre, Alexandre
    Baumstarck, Karine
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [22] Marfan syndrome in childhood: parents' perspectives of the impact on daily functioning of children, parents and family; a qualitative study
    Warnink-Kavelaars, Jessica
    Beelen, Anita
    Dekker, Sarah
    Nollet, Frans
    Menke, Leonie A.
    Engelbert, Raoul H. H.
    BMC PEDIATRICS, 2019, 19 (1)
  • [23] The Impact of Educating Parents of Leukemic Children on the Patients' Quality of Life
    Hashemi, F.
    Asadi, N.
    Beheshtipour, N.
    Karimi, M.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2011, 13 (08) : 550 - 555
  • [24] A two-year prospective study of the health-related quality of life of children with chronic illness – the parents’ perspective
    M. G. Sawyer
    K. E. Reynolds
    J. J. Couper
    D. J. French
    D. Kennedy
    J. Martin
    R. Staugas
    P. A. Baghurst
    Quality of Life Research, 2005, 14 : 395 - 405
  • [25] Health-related quality of life in children with and without chronic conditions. A multicenter study
    Rivera, Carolina
    Mamondi, Veronica
    Lavin Fueyo, Julieta
    Francisco Jouglard, Ezequiel
    Pogany, Lourdes
    Camila Sanchez, Maria
    Prina, Martina
    Roizen, Mariana
    Eugenia Esandi, Maria
    Berra, Silvina
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2015, 113 (05): : 404 - 410
  • [26] Influences on preschool children's oral health-related quality of life as reported by English and Spanish-speaking parents and caregivers
    Born, Catherine D.
    Divaris, Kimon
    Zeldin, Leslie P.
    Rozier, R. Gary
    JOURNAL OF PUBLIC HEALTH DENTISTRY, 2016, 76 (04) : 276 - 286
  • [27] The impact of the family-centered empowerment model on the children's quality of life with chemical burns and their parent's perceived stress
    Mohammadzadeh, Elham
    Varzeshnejad, Maryam
    Masoumpour, Anahita
    Ahmadimehr, Farzaneh
    BURNS, 2023, 49 (04) : 838 - 847
  • [28] Hidden Victims of Childhood Vitiligo: Impact on Parents' Mental Health and Quality of Life
    Amer, Abdulrahman A. A.
    Mchepange, Uwesu O.
    Gao, Xing-Hua
    Hong, Yuxiao
    Qi, Ruiqun
    Wu, Yan
    Cai, Yunfei
    Zhai, Jinlong
    Chen, Hong-Duo
    ACTA DERMATO-VENEREOLOGICA, 2015, 95 (03) : 322 - 325
  • [29] The impact of influenza-like illness in young children on their parents: a quality of life survey
    Chow, Maria Yui Kwan
    Yin, Jiehui Kevin
    Heron, Leon
    Morrow, Angela
    Dierig, Alexa
    Booy, Robert
    Leask, Julie
    QUALITY OF LIFE RESEARCH, 2014, 23 (05) : 1651 - 1660
  • [30] The Impact of Childhood Acute Otitis Media on Parental Quality of Life in a Prospective Observational Cohort Study
    Holl, Katsiaryna
    Rosenlund, Mats
    Giaquinto, Carlo
    Silfverdal, Sven-Arne
    Carmona, Alfonso
    Larcombe, James
    Garcia-Sicilia, Jose
    Fuat, Ahmet
    Eulalia Munoz, Maria
    Luisa Arroba, Maria
    Sloesen, Brigitte
    Vollmar, Jens
    Pircon, Jean-Yves
    Liese, Johannes G.
    CLINICAL DRUG INVESTIGATION, 2015, 35 (10) : 613 - 624